Skip to main content

Adaptimmune Therapeutics plc - American Depositary Shares (NQ:ADAP)

0.2530 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 8, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 36
Open 0.2530
Bid (Size) 0.2530 (20)
Ask (Size) 0.2600 (19)
Prev. Close 0.2530
Today's Range 0.2530 - 0.2530
52wk Range 0.1951 - 1.480
Shares Outstanding 1,535,653,620
Dividend Yield N/A

Performance

YTD
-59.4%
-59.4%
1 Month
-10.2%
-10.2%
3 Month
+12.1%
+12.1%
6 Month
-61.3%
-61.3%
1 Year
-78.2%
-78.2%

More News

Read More

Frequently Asked Questions

Is Adaptimmune Therapeutics plc - American Depositary Shares publicly traded?
Yes, Adaptimmune Therapeutics plc - American Depositary Shares is publicly traded.
What exchange does Adaptimmune Therapeutics plc - American Depositary Shares trade on?
Adaptimmune Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Adaptimmune Therapeutics plc - American Depositary Shares?
The ticker symbol for Adaptimmune Therapeutics plc - American Depositary Shares is ADAP on the Nasdaq Stock Market
What is the current price of Adaptimmune Therapeutics plc - American Depositary Shares?
The current price of Adaptimmune Therapeutics plc - American Depositary Shares is 0.2530
When was Adaptimmune Therapeutics plc - American Depositary Shares last traded?
The last trade of Adaptimmune Therapeutics plc - American Depositary Shares was at 07/08/25 04:00 PM ET
What is the market capitalization of Adaptimmune Therapeutics plc - American Depositary Shares?
The market capitalization of Adaptimmune Therapeutics plc - American Depositary Shares is 388.52M
How many shares of Adaptimmune Therapeutics plc - American Depositary Shares are outstanding?
Adaptimmune Therapeutics plc - American Depositary Shares has 389M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.